Proscar contains finasteride and is prescribed for adult men with benign prostatic hyperplasia (BPH). By reducing dihydrotestosterone formation, it can help the prostate shrink gradually and improve urinary symptoms. The regimen for the selected strength should be confirmed with a healthcare professional before starting.
Proscar contains finasteride and is prescribed for adult men with Benign Prostatic Hyperplasia (BPH). BPH develops when prostate tissue enlarges around the urethra, the tube that carries urine from the bladder. The resulting pressure can weaken the urine stream and make bladder emptying harder.
Proscar is supplied as oral tablets for BPH. The regimen for the selected strength should be confirmed with a healthcare professional before starting.
The appropriate strength and regimen for BPH should be confirmed with a healthcare professional before treatment begins. Clinicians may review symptom response, prostate findings, urinary flow, PSA results, and tolerability during follow-up.
Finasteride may be used alone or as part of a broader BPH treatment plan. The correct regimen depends on prostate size, symptom severity, urinary complications, and other medicines being taken.
Finasteride tablets should be swallowed whole when possible. Pregnant people, or people who could become pregnant, should not handle crushed or broken tablets because finasteride exposure may affect development of male genital organs in a male fetus.
An intact tablet has a protective coating that reduces direct contact with the active ingredient. If a tablet breaks, avoid handling the fragments with bare hands. A pharmacist can provide specific advice about safe handling of intact tablets and any damaged tablet.
Proscar contains finasteride as its active ingredient. It is prescribed for adult men with benign prostatic hyperplasia (BPH), in which enlarged prostate tissue can put pressure on the urethra and affect urination.
Finasteride inhibits steroid 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT). By reducing DHT formation in prostate tissue, it lowers androgen stimulation of the prostate. This allows prostate volume to decline gradually and can relieve pressure on the urethra.
Proscar contains finasteride and is prescribed for adult men with Benign Prostatic Hyperplasia (BPH). BPH develops when prostate tissue enlarges around the urethra, the tube that carries urine from the bladder. The resulting pressure can weaken the urine stream and make bladder emptying harder.
Common BPH symptoms include:
BPH symptoms can resemble urinary infection, bladder disease, urethral narrowing, neurological bladder problems, or prostate cancer. A clinician may assess the medical history, perform an examination, request urine testing, and decide whether prostate-specific antigen (PSA) testing or other evaluation is appropriate.
Proscar is intended for men with an enlarged prostate and lower urinary tract symptoms. It is not a treatment for urinary infection. Burning urination, fever, blood in the urine, severe pelvic pain, or sudden inability to urinate needs prompt medical assessment.
Finasteride works gradually because it changes prostate biology rather than simply relaxing bladder-neck or prostate muscle. Some men notice urinary improvement after several weeks, while the full benefit may take several months. The Canadian product information describes the need for continued treatment to maintain the reduction in prostate-related obstruction [1].
Frequent mistakes include:
One detail patients often miss is that symptom improvement and prostate shrinkage do not progress at the same speed. Another is that a stable urinary pattern does not make PSA disclosure optional.
Proscar is not suitable for everyone. NOT for you if you need immediate relief or have unexplained urinary symptoms; seek medical assessment first. The medicine requires careful consideration in people with liver disease, unexplained urinary symptoms, previous prostate evaluation, or significant sexual or mood symptoms.
Finasteride is intended for men with BPH. Pregnant people should not take it and should avoid contact with crushed or broken tablets. The concern relates to potential exposure during development of male fetal genital organs.
Men taking Proscar should tell household members about the tablet-handling precaution. Intact tablets can be handled normally, while fragments require extra care.
Health Canada provides Canadian medication and safety information through its product-monograph framework [3].
Finasteride is tolerated by many men, though sexual and breast-related effects are clinically relevant. Possible adverse effects include reduced libido, erectile difficulty, reduced ejaculate volume, breast tenderness, and breast enlargement. Mood changes, including depressed mood, have also been reported.
Sexual symptoms may occur during treatment and may improve while treatment continues or after discontinuation. Persistent sexual symptoms deserve medical review rather than silent acceptance, especially when they affect relationships, mood, or quality of life.
Breast enlargement or tenderness should be reported, especially if a lump, nipple discharge, or one-sided breast change develops. These symptoms can have causes unrelated to finasteride and should not be self-diagnosed.
Seek prompt medical assessment for:
Sudden urinary retention is an emergency because the bladder may become painfully overfilled. Do not assume that rapidly worsening urinary symptoms are simply part of ordinary BPH.
BPH treatment is selected according to prostate size, urinary symptoms, flow limitation, complications, other medicines, and patient preference. Proscar acts slowly but can reduce prostate volume. Alpha blockers often improve urine flow sooner, yet they do not shrink the prostate.
| Treatment approach | Main action and limitation |
|---|---|
| Proscar, a 5-alpha-reductase inhibitor | Gradually reduces DHT-driven prostate growth; sexual adverse effects can occur and symptom relief is slow |
| Alpha blocker | Relaxes prostate and bladder-neck muscle; may act sooner but can cause dizziness or blood-pressure-related symptoms |
| Procedure or surgery | Removes or bypasses obstructing tissue; considered when medicines fail or complications develop |
Alpha blockers reduce smooth-muscle tension around the prostate and bladder outlet. Their effect can appear earlier than the prostate-volume reduction produced by finasteride. They do not reduce the underlying prostate size. The effect is faster.
Proscar may be favoured when the prostate is enlarged and long-term reduction in progression risk is a treatment goal. An alpha blocker may be used when rapid improvement in urinary flow is needed. Some men receive both, with monitoring for dizziness, falls, sexual adverse effects, and blood-pressure changes.
Combining a 5-alpha-reductase inhibitor with an alpha blocker can address two different mechanisms: prostate growth and muscle tone. Combination treatment also increases the need for medication review because adverse effects from either medicine may overlap.
A clinician may reassess the need for both medicines after sustained treatment. Do not stop one component independently if the combination was prescribed for persistent obstruction or a high risk of urinary retention.
A minimally invasive procedure or surgery related to BPH may be considered when symptoms remain troublesome, urinary retention recurs, bladder stones develop, bleeding persists, or obstruction affects kidney function. Surgery is not automatically required for every enlarged prostate.
A urology assessment helps determine whether medication remains suitable or whether a procedure offers a better balance between symptom relief and treatment burden. The American Urological Association guideline supports treatment selection based on symptom severity, prostate characteristics, complications, and patient priorities [2].
In clinical practice, doctors generally frame Proscar as a long-term prostate treatment rather than a rapid symptom reliever. The benefit is assessed through urinary symptoms, flow, residual urine, prostate findings, and adverse effects. A patient may feel little change during the first weeks while the biological effect is developing.
Clinicians also watch for symptoms that need a different diagnosis. Fever, painful urination, visible blood, severe pain, or sudden retention should not be attributed automatically to BPH. New symptoms can require urine testing, imaging, or urological assessment.
Store Proscar tablets in a dry place at room temperature and keep them away from excessive heat and moisture. Keep the tablets in their original protective packaging during travel and out of reach of children. Do not leave them in a hot vehicle, damp bathroom, or direct sunlight. Health Canada’s 2023 medication guidance advises following the storage conditions assigned to the specific medicine and keeping medication information available during travel.
Alcohol does not directly block finasteride’s conversion of testosterone to DHT, but it can worsen nocturia, urgency, sleep disruption, dizziness, or sexual difficulties in some men. Drinking heavily may also make it harder to remember a daily tablet. The WHO’s 2024 alcohol guidance describes alcohol as a contributor to several health risks, while finasteride-specific prescribing information focuses on its hormonal mechanism and adverse-effect profile. Moderate use may be tolerated, but stop and seek help for severe dizziness, fainting, or worsening urinary symptoms.
Proscar contains finasteride, which lowers DHT and gradually reduces prostate volume. An alpha blocker relaxes smooth muscle around the bladder outlet and prostate, so urinary flow may improve sooner without shrinking the prostate. The 2023 AUA BPH guideline explains that treatment selection depends on prostate features, symptoms, complications, and patient preferences. Some men use both approaches when a single mechanism does not provide adequate relief.
Discuss liver disease, previous prostate tests, urinary retention, blood in the urine, breast symptoms, mood changes, fertility concerns, and all current medicines. The clinician should know whether PSA testing is planned because finasteride changes how PSA results are interpreted. Health Canada’s 2023 medication information supports reviewing medical history and treatment response during follow-up. Confirming the regimen for the chosen strength before starting is also important.
Pregnancy rules out Proscar use, and pregnant people should not handle crushed or broken finasteride tablets. A known serious allergy to finasteride or an ingredient in the tablet also rules out treatment. Men with sudden urinary retention should receive urgent assessment rather than relying on Proscar for immediate relief. The 2023 EMA product information and national regulators identify pregnancy exposure and hypersensitivity as key safety concerns for finasteride products.
Your order will be securely packed and shipped within 24 hours. This is exactly what your package will look like (images of an actual item sent). It has the size and look of a regular private letter (24x11x0.7 cm) and its contents cannot be seen.
I used Proscar for several months and noticed that getting started in the morning became easier. The night-time trips reduced gradually, so the improvement was clearer when I compared it with my earlier routine.
After taking the tablets consistently, my stream felt stronger and I was not planning my evenings around bathroom stops as much. It took patience, but the change became noticeable over time.
Proscar did not make enough difference for my urinary symptoms. I stopped after discussing the lack of benefit with my doctor and needed a different plan for the enlarged prostate.
The urinary symptoms improved somewhat, although I noticed reduced sexual interest during treatment. The benefit was real but limited, and I discussed the trade-off at a follow-up appointment.
My main problem had been waking repeatedly at night. After a longer period of regular use, I was sleeping through more often and felt less bothered by the weak stream.
